z-logo
open-access-imgOpen Access
Clinical use of vorapaxar as an emerging antithrombin agent: A literature review of current evidence
Author(s) -
FarjahH Algahtani
Publication year - 2017
Publication title -
journal of applied hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.107
H-Index - 2
eISSN - 2454-6976
pISSN - 1658-5127
DOI - 10.4103/joah.joah_41_17
Subject(s) - medicine , stroke (engine) , thrombosis , cardiology , revascularization , acute coronary syndrome , platelet aggregation inhibitor , intensive care medicine , myocardial infarction , aspirin , engineering , mechanical engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom